Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2003
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003091675A3 Ultrasonic doppler effect speed measurement
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003068725A3 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463266A Binaphthol derivative and method for producing same
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/23/2003US6667414 Renin inhibitors; hypertensive agents
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667328 Such as 2-(N-Cyanoimino)-5-((E)-4-styrylbenzylidene)thiazol-idin-4-one; prophylaxis of hypolipidemic/hypoglycemic, hyper-/hypo-cholesterolemia activity
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667307 HIV protease
12/23/2003CA2208032C Substituted amidinonaphthyl ester derivative
12/23/2003CA2116387C Oxazolidinedione derivatives, their production and use
12/18/2003WO2003103686A1 Thrombopoietin mimetics
12/18/2003WO2003103665A1 Antiallergic
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003074504A3 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
12/18/2003WO2003051795A3 Resin-bonded isonitriles
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232830 Non-covalent inhibitors of AmpC beta-lactamase
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030230530 Dissolving Famotidine crude in methanol under heating and stirring to form solution, adding activated carbon, filtering, concentrating under vacuum at 45-58 degrees C, filtering, drying crystals of Famotidin polymorphs A and B
12/18/2003US20030229950 Hair dyes
12/18/2003CA2488367A1 Antiallergic agents
12/17/2003EP1371651A2 N-alkylated Thiazoliumsalts and processes for their preparation
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1370543A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP0984981B1 Anti-inflammatory tyrosine derivatives
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1131461C Photosensitive compounds, photosensitive resin compositions and method for pattern formation making use of compounds and compositions
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664281 Oxazol-4-yl-alkoxy- or alkthioxy- functionality; peroxisome proliferator activated receptor regulators
12/16/2003US6664025 Ethylenically unsaturated monomer capable of free radical addition polymerizatio catalysis; binder, photoinitiator and cyanopyidone sensitizer; metallocene and onium coninitiators
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003102109A1 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229138 Aza hydroxylated ethyl amine compounds utility
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/10/2003EP1369861A2 Optical recording media
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369129A1 Remedies for depression containing ep1 antagonist as the active ingredient
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0893995B1 Anticachectic composition
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660757 Use of riluzole in the treating acoustic traumas
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660529 Heteroaryl substituted benzothiazole dioxetanes
12/09/2003US6660466 Reacting reactive appendage compounds such as meta benzylic compounds or alpha-amide compounds with scaffold molecules having reactive functionalities and contacting the intermediate library with a reducing agent
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099777A1 Process for the preparation of thioalkylamine derivatives
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003US20030225287 Synthesis of chiral 2-alkyl amino acids
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225274 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates
12/04/2003US20030225252 PNA monomer and precursor
12/04/2003US20030225147 Inhibit activity of protein kinases; for tumor growth, angiogenesis, viral infection, autoimmune disease or neurodegenerative disorder
12/04/2003US20030225146 Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds
12/04/2003US20030225141 Thiazole derivatives
12/04/2003US20030225140 Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/04/2003US20030225127 Heterocyclic sulfonamide derivatives
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225071 N-heterocyclic amides and carbamates
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 337